NSE ScannerChemicals · Chemicals: Specialty · NSE: ARVEE · data 2026-10-31
Arvee Laboratories (India) Ltd.
In plain words
Price: 28.9% below its 52-week high of ₹290.78.
Delivery: 66.0% of traded shares were kept for delivery over the last 10 sessions, against 55.0% over the last 60.
Latest results: a net profit of ₹2 cr for the quarter ended Jun 2026 (+894.1% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹41 cr |
| Net profit (last 12 months) | ₹4 cr |
| Sales growth, 3 years (yearly) | -19.9% |
| Profit growth, 3 years (yearly) | -15.0% |
At a glance
Promoters 73.5% (unchanged in a year), pledged 0.0%.
P/E 56.2, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 7.8%, ROCE 5.7%, operating margin 10.0%: how much profit it earns on the money it uses.
Debt/equity 0.03, Profit growth -15.0% and sales growth -19.9% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Low return on equity (7.8%).
- Profit fell 15.0% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
ARVEE Q1 FY27 results (standalone figures, as filed on NSE).
Revenue was ₹17.23 crore, up 130.3% YoY and up 59.5% QoQ.
Net profit was ₹1.69 crore, up 894.1% YoY and up 225% QoQ.
Operating margin was 14.5% (4.6% a year ago).
EPS was ₹1.54, up 926.7% YoY and up 227.7% QoQ.
ARVEE के Q1 FY27 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
राजस्व: ₹17.23 करोड़; पिछले साल की तुलना में 130.3% की बढ़त, पिछली तिमाही की तुलना में 59.5% की बढ़त।
शुद्ध मुनाफ़ा: ₹1.69 करोड़; पिछले साल की तुलना में 894.1% की बढ़त, पिछली तिमाही की तुलना में 225% की बढ़त।
ऑपरेटिंग मार्जिन: 14.5% (एक साल पहले 4.6%)।
EPS: ₹1.54; पिछले साल की तुलना में 926.7% की बढ़त, पिछली तिमाही की तुलना में 227.7% की बढ़त।
ARVEEના Q1 FY27 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹17.23 કરોડ; ગયા વર્ષની સરખામણીએ 130.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 59.5% વધારો.
ચોખ્ખો નફો: ₹1.69 કરોડ; ગયા વર્ષની સરખામણીએ 894.1% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 225% વધારો.
ઓપરેટિંગ માર્જિન: 14.5% (એક વર્ષ પહેલાં 4.6%).
EPS: ₹1.54; ગયા વર્ષની સરખામણીએ 926.7% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 227.7% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
15/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 10/30: Delivery 54.4% over the last 20 sessions vs 30.7% in the 40 before (1.77x); shares delivered per day 0.6x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 7 Aug 26Results Q1 FY27 results: profit +894.1% YoY -0.4% next session
- 19 May 26Results Q4 FY26 results: profit +642.9% YoY +4.0% next session
- 16 Feb 26Results Q3 FY26 results: profit +1120.0% YoY +8.5% next session
- 14 Nov 25Results Q2 FY26 results: profit −99.0% YoY -0.7% next session
- 12 Aug 25Results Q1 FY26 results: profit −81.9% YoY +3.0% next session
- 9 May 25Results Q4 FY25 results: profit −41.7% YoY -1.3% next session
- 12 Feb 25Results Q3 FY25 results: profit −37.5% YoY -2.5% next session
- 14 Nov 24Results Q2 FY25 results: net profit ₹1 cr +1.5% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹17 cr | ₹2 cr | +894.1% | 14.5% | 1.54 |
| Mar 2026 | ₹11 cr | ₹1 cr | +642.9% | 10.2% | 0.47 |
| Dec 2025 | ₹10 cr | ₹2 cr | +1120.0% | 16.6% | 1.66 |
| Sept 2025 | ₹3 cr | ₹0 cr | -99.0% | 3.7% | 0.01 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 73.50% | 73.50% | 73.50% | 73.50% |
| Foreign institutions (FII) | — | — | — | — |
| Domestic institutions (DII) | — | — | — | — |
| Mutual funds | — | — | — | — |
| Retail investors | 1.96% | 1.88% | 1.93% | 1.96% |
| Number of shareholders | 1,947 | 1,596 | 1,638 | 1,861 |
Common questions
What was Arvee Laboratories (India) Ltd.'s latest quarterly profit?
Arvee Laboratories (India) Ltd. reported a net profit of ₹2 cr for the quarter ended Jun 2026 (+894.1% on the same quarter a year earlier), on revenue of ₹17 cr.
How much do promoters hold in Arvee Laboratories (India) Ltd.?
Promoters held 73.50% of Arvee Laboratories (India) Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Arvee Laboratories (India) Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.03, which is very low.
What is Arvee Laboratories (India) Ltd.'s P/E ratio?
About 56.2, based on the last 12 months' earnings and a price of ₹206.71 (data 2026-10-31).
What is the 52-week high and low of Arvee Laboratories (India) Ltd.?
The 52-week high is ₹290.78 and the 52-week low is ₹129.11.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Arvee Laboratories (India) Ltd. | ₹206.71 | ₹228 cr | 56.2 | — | 7.8% | 5.7% | 0.03 | +27.6% |
| AksharChem India Ltd. | ₹376.95 | ₹300 cr | 10.5 | 1 | -0.2% | -3.4% | 0.41 | +34.0% |
| Sayaji Industries Limited | ₹109 | ₹290 cr | 11.1 | 2.7 | 1.5% | 10.6% | 2.45 | -12.8% |
| Dai-Ichi Karkaria Limited | ₹314 | ₹235 cr | 107.8 | — | -0.4% | -3.1% | 0.07 | +21.3% |
| Ducol Organics & Colours Ltd. | ₹115 | ₹208 cr | 25.9 | 1.9 | 7.7% | 11.1% | 0.44 | -38.8% |
| IVP Ltd | ₹181.13 | ₹190 cr | 5.9 | — | 12.6% | 18.6% | 0.42 | +10.6% |
Compare ARVEE with AKSHARCHEM in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ARVEE in NSE Scanner →